tiprankstipranks
Trending News
More News >
Draegerwerk AG & Co. KGaA (DE:DRW3)
:DRW3

Draegerwerk AG & Co. KGaA (DRW3) AI Stock Analysis

Compare
4 Followers

Top Page

DE

Draegerwerk AG & Co. KGaA

(LSE:DRW3)

Rating:77Outperform
Price Target:
€78.00
▲(11.27%Upside)
Draegerwerk AG & Co. KGaA achieves a strong overall stock score due to robust technical analysis and attractive valuation. The financial performance is solid, but challenges in revenue growth and free cash flow limit the score.
Positive Factors
Earnings
Several one-time effects positively influenced earnings, contributing approximately €22m to EBIT.
Order Intake
The preliminary order intake increased by approximately 6.1%, particularly due to significant growth in the EMEA region.
Negative Factors
Net Sales
Dräger saw a decrease in net sales of 1.2%, mainly attributed to a weaker performance in the medical division.
US Tariff Policy
The potential impact of the US tariff policy on business development is currently unpredictable and not included in the forecast.

Draegerwerk AG & Co. KGaA (DRW3) vs. iShares MSCI Germany ETF (EWG)

Draegerwerk AG & Co. KGaA Business Overview & Revenue Model

Company DescriptionDraegerwerk AG & Co. KGaA is a German-based company specializing in the fields of medical and safety technology. It operates primarily through two segments: the medical division and the safety division. The medical division provides solutions such as anesthesia workstations, ventilators for intensive care, emergency, and mobile ventilation units, as well as warming therapy equipment for infants. The safety division offers products and services related to personal protection, gas detection technology, and professional diving equipment. Draegerwerk serves a global customer base across various industries, including healthcare, industrial, mining, and emergency services.
How the Company Makes MoneyDraegerwerk AG & Co. KGaA generates revenue through the sale of its medical and safety products, as well as through the provision of related services. The medical division earns income by supplying hospitals and healthcare facilities with critical care equipment such as ventilators and anesthesia machines, which are essential for patient care. The safety division contributes to the company's revenue by offering safety solutions like portable gas detection devices, respiratory protection equipment, and occupational safety training services. Draegerwerk's earnings are supported by long-term contracts and partnerships with healthcare institutions and industrial corporations, ensuring steady demand for its products and services. The company also invests in research and development to innovate and improve its offerings, thereby maintaining its competitiveness and market presence.

Draegerwerk AG & Co. KGaA Financial Statement Overview

Summary
Income Statement
Balance Sheet
Cash Flow
Breakdown
TTMDec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Income StatementTotal Revenue
3.00B3.37B3.05B3.33B3.41B2.78B
Gross Profit
1.27B1.46B1.24B1.54B1.61B1.19B
EBIT
-45.05M171.18M-79.76M280.89M411.53M84.27M
EBITDA
107.02M318.33M62.63M422.66M520.22M190.79M
Net Income Common Stockholders
-63.28M110.43M-63.64M154.23M188.59M33.35M
Balance SheetCash, Cash Equivalents and Short-Term Investments
211.70M279.36M306.67M572.16M639.08M191.50M
Total Assets
3.03B3.09B3.11B3.18B3.31B2.57B
Total Debt
285.94M471.38M361.95M348.01M370.75M285.00M
Net Debt
74.24M199.43M59.49M-91.43M-121.48M96.57M
Total Liabilities
1.59B1.69B1.79B1.92B2.27B1.49B
Stockholders Equity
1.43B1.41B1.32B1.26B1.03B1.07B
Cash FlowFree Cash Flow
-102.04M121.47M-231.09M274.54M345.04M100.03M
Operating Cash Flow
-2.25M189.68M-144.23M384.89M459.98M164.42M
Investing Cash Flow
-103.93M-67.34M36.83M-109.92M-263.08M-62.07M
Financing Cash Flow
-120.55M-154.56M-29.38M-334.64M114.25M-87.87M

Draegerwerk AG & Co. KGaA Technical Analysis

Technical Analysis Sentiment
Positive
Last Price70.10
Price Trends
50DMA
61.89
Positive
100DMA
58.15
Positive
200DMA
51.17
Positive
Market Momentum
MACD
2.57
Negative
RSI
80.11
Negative
STOCH
92.91
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:DRW3, the sentiment is Positive. The current price of 70.1 is above the 20-day moving average (MA) of 65.50, above the 50-day MA of 61.89, and above the 200-day MA of 51.17, indicating a bullish trend. The MACD of 2.57 indicates Negative momentum. The RSI at 80.11 is Negative, neither overbought nor oversold. The STOCH value of 92.91 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DE:DRW3.

Draegerwerk AG & Co. KGaA Peers Comparison

Overall Rating
UnderperformOutperform
Sector (54)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
77
Outperform
€1.17B10.578.06%2.93%0.51%
DESHL
77
Outperform
€51.92B24.9411.14%1.97%5.83%13.44%
DEFME
68
Neutral
€14.82B23.974.37%2.86%0.10%27.83%
DEAFX
64
Neutral
€5.30B33.467.48%1.01%5.21%-39.36%
DECOP
59
Neutral
€1.16B33.075.26%4.52%-2.84%-24.28%
54
Neutral
$5.24B3.27-45.39%2.80%16.77%-0.07%
DEEVT
48
Neutral
€1.24B-20.51%1.50%-127.76%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
DE:DRW3
Draegerwerk AG & Co. KGaA
71.60
22.85
46.87%
DE:FME
Fresenius Medical Care AG & Co. KGaA
50.32
12.05
31.49%
DE:COP
CompuGroup Medical
22.04
-3.10
-12.33%
DE:AFX
Carl Zeiss Meditec
60.10
-25.06
-29.43%
DE:EVT
Evotec
7.06
-1.63
-18.71%
DE:SHL
Siemens Healthineers AG
46.65
-7.24
-13.43%
Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.